Literature DB >> 16670813

[Antirheumatic therapy and reproduction. The influence on fertility, pregnancy and breast feeding].

M Ostensen1.   

Abstract

Antirheumatic drugs can have a negative effect on reproduction in both men and women. Possible negative effects are impairment of fertility, harmful effects on the fetus and adverse effects on the breastfed child. In women non-steroidal antiinflammatory drugs (NSAID) and cyclophosphamide can impair fertility. In men infertility can result from the use of salazopyrine and cyclophosphamide. A desire for children should be taken into account before the start of disease modifying drugs (DMARD). Treatment with NSAID is possible at some stages of pregnancy as well as during lactation. A limited number of DMARD is compatible with pregnancy and is presented. Cytostatic drugs and leflunomide must be prophylactically withdrawn before a planned pregnancy. TNF alpha antagonists should be discontinued at the start of pregnancy. Safe birth control must be practised during therapy with drugs that are gonadotoxic or teratogenic. Treatment with immunosuppressive drugs during lactation is limited because of insufficient documentation of safety for the breastfed child.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16670813     DOI: 10.1007/s00393-006-0052-5

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  28 in total

Review 1.  Preserving ovarian function in patients receiving cyclophosphamide.

Authors:  C A Slater; M H Liang; J W McCune; G M Christman; M R Laufer
Journal:  Lupus       Date:  1999       Impact factor: 2.911

2.  Teratogen update: azathioprine and 6-mercaptopurine.

Authors:  Janine E Polifka; J M Friedman
Journal:  Teratology       Date:  2002-05

Review 3.  Analgesics and breast-feeding: safety considerations.

Authors:  O Spigset; S Hägg
Journal:  Paediatr Drugs       Date:  2000 May-Jun       Impact factor: 3.022

Review 4.  Antimalarial drugs in systemic lupus erythematosus: use in pregnancy.

Authors:  M B Borden; A L Parke
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

5.  Pregnancy outcome after cyclosporine therapy during pregnancy: a meta-analysis.

Authors:  B Bar Oz; R Hackman; T Einarson; G Koren
Journal:  Transplantation       Date:  2001-04-27       Impact factor: 4.939

Review 6.  Low dose weekly methotrexate in early pregnancy. A case series and review of the literature.

Authors:  M Ostensen; H Hartmann; K Salvesen
Journal:  J Rheumatol       Date:  2000-08       Impact factor: 4.666

7.  Gonadal function in male adolescents and young males with juvenile onset systemic lupus erythematosus.

Authors:  Clovis A A Silva; Jorge Hallak; Fabio F Pasqualotto; Mário F Barba; Maria I Saito; Maria H B Kiss
Journal:  J Rheumatol       Date:  2002-09       Impact factor: 4.666

8.  Risk for sustained amenorrhea in patients with systemic lupus erythematosus receiving intermittent pulse cyclophosphamide therapy.

Authors:  D T Boumpas; H A Austin; E M Vaughan; C H Yarboro; J H Klippel; J E Balow
Journal:  Ann Intern Med       Date:  1993-09-01       Impact factor: 25.391

9.  The use of disease modifying antirheumatic drugs in women with rheumatoid arthritis of childbearing age: a survey of practice patterns and pregnancy outcomes.

Authors:  Eliza F Chakravarty; Deanna Sanchez-Yamamoto; Thomas M Bush
Journal:  J Rheumatol       Date:  2003-02       Impact factor: 4.666

10.  Pregnancy in inflammatory bowel disease: effect of sulfasalazine and corticosteroids on fetal outcome.

Authors:  M Mogadam; W O Dobbins; B I Korelitz; S W Ahmed
Journal:  Gastroenterology       Date:  1981-01       Impact factor: 22.682

View more
  5 in total

Review 1.  [Ophthalmic agents during pregnancy and breastfeeding].

Authors:  T Ness; W Paulus
Journal:  Ophthalmologe       Date:  2012-03       Impact factor: 1.059

Review 2.  [Drug therapy during pregnancy and breast feeding. Updated summary].

Authors:  K Krüger; E Gromnica-Ihle
Journal:  Z Rheumatol       Date:  2009-03       Impact factor: 1.372

Review 3.  Ocular changes during pregnancy.

Authors:  Friederike Mackensen; Wolfgang E Paulus; Regina Max; Thomas Ness
Journal:  Dtsch Arztebl Int       Date:  2014-08-18       Impact factor: 5.594

Review 4.  [Systemic sclerosis and pregnancy. A review of the current literature].

Authors:  A Németh; S Szamosi; A Horváth; J Schönherr; E Nicksch; Z Szekanecz; G Szűcs
Journal:  Z Rheumatol       Date:  2014-03       Impact factor: 1.372

Review 5.  Uveitis and gender: the course of uveitis in pregnancy.

Authors:  Nathalie P Y Chiam; Lyndell L P Lim
Journal:  J Ophthalmol       Date:  2014-01-09       Impact factor: 1.909

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.